References
1. Nelson AL, Dhimolea E, Reichert
JM. Development trends for human monoclonal antibody therapeutics.Nat. Rev. Drug Discov. 2010;9(10):767–774.
2. Jacobse J, Ten Voorde W, Rissmann R, Burggraaf J, Ten Cate R, Schrier
L. The effect of repeated methotrexate injections on the quality of life
of children with rheumatic diseases. Eur. J. Pediatr.2019;178(1):17–20.
3. Donnelly RF, Raghu Raj Singh T, Larraneta. E, McCrudden MTC.Microneedles for Drug and Vaccine Delivery and Patient
Monitoring . Chichester, UK: John Wiley & Sons, Ltd; 2018.
4. Gupta J, Felner EI, Prausnitz MR. Rapid Pharmacokinetics of
Intradermal Insulin Administered Using Microneedles in Type 1 Diabetes
Subjects. Diabetes Technol. Ther. 2011;13(4):451–456.
5. McVey E, Hirsch L, Sutter DE, Kapitza C, Dellweg S, Clair J, Rebrin K
… Pettis RJ. Pharmacokinetics and
postprandial glycemic excursions following insulin lispro delivered by
intradermal microneedle or subcutaneous infusion. J Diabetes Sci
Technol. 2012;6(4):743–754.
6. Kochba E, Levin Y, Raz I, Cahn A. Improved Insulin Pharmacokinetics
Using a Novel Microneedle Device
for Intradermal Delivery in Patients with Type 2 Diabetes.Diabetes Technol. Ther. 2016;18(9):525–531.
7. Milewski M, Manser K, Nissley BP, Mitra A. Analysis of the absorption
kinetics of macromolecules
following intradermal and subcutaneous administration. Eur. J.
Pharm. Biopharm. 2015;89:134–144.
8. Hróbjartsson A, Emanuelsson F, Thomsen ASS, Hilden J, Brorson S. Bias
due to lack of patient blinding in
clinical trials. A systematic review of trials randomizing patients to
blind and nonblind sub-studies. Int. J.
Epidemiol. 2014;43(4):1272–1283.
9. Levin Y, Kochba E, Kenney R. Clinical evaluation of a novel
microneedle device for intradermal delivery of
an influenza vaccine: Are all delivery methods the same? Vaccine2014;32(34):4249–4252.
10. Mahler SM, Marquis CP, Brown G, Roberts A, Hoogenboom HR. Cloning
and expression of human V-
genes derived from phage display libraries as fully assembled human
anti-TNFα monoclonal antibodies.Immunotechnology 1997;3(1):31–43.
11. Hermeling S, Crommelin DJA, Schellekens H, Jiskoot W.
Structure-immunogenicity relationships of therapeutic proteins.Pharm. Res. 2004;21(6):897–903.
12. Bartelds GM, Wijbrandts CA, Nurmohamed MT, Stapel S, Lems WF, Aarden
L … Wolbink GJ. Clinical response to adalimumab: Relationship to
anti-adalimumab antibodies and serum adalimumab concentrations in
rheumatoid arthritis. Ann. Rheum. Dis. 2007;66(7):921–926.
13. Bartelds GM, Krieckaert CLM, Nurmohamed MT, Van Schouwenburg PA,
Lems WF, Twisk JWR … Wolbink JG. Development of Antidrug
Antibodies Against Adalimumab and Association With Disease Activity
and
Treatment Failure During Long-term Follow-up. JAMA2011;305(14):1460.
14. Dillingh MR, Reijers JAA, Malone KE, Burggraaf J, Bahrt K, Yamashita
L … Moerland M. Clinical evaluation
of humira® biosimilar ons-3010 in healthy volunteers: Focus on
pharmacokinetics and
pharmacodynamics. Front. Immunol. 2016;7:508.
15. Hicks CL, Von Baeyer CL, Spafford PA, Van Korlaar I, Goodenough B.
The Faces Pain Scale - Revised: Toward a common metric in pediatric pain
measurement. Pain. 2001;93(2):173–83.
16. Pouw MF, Krieckaert CL, Nurmohamed MT, Van Der Kleij D, Aarden L,
Rispens T, et al. Key findings towards optimising adalimumab treatment:
The concentration-effect curve. Ann Rheum Dis. 2015;74(3):513–8.
17. Briers D, Duncan DD, Hirst E, Kirkpatrick SJ, Larsson M, Steenbergen
W, Stromberg T, Thompson OB. Laser speckle contrast imaging: theoretical
and practical limitations. J. Biomed. Opt. 2013;18(6):066018.
18. Everett JS, Budescu M, Sommers MS. Making Sense of Skin Color in
Clinical Care. Clin Nurs Res. 2012;21(4):495–516.
19. Del Bino S, Bernerd F. Variations in skin colour and the biological
consequences of ultraviolet radiation exposure. Br J Dermatol.
2013;169(SUPPL. 3):33–40.
20. Vlieland ND, Nejadnik MR, Gardarsdottir H, Romeijn S, Sediq AS,
Bouvy ML … Jiskoot W. The Impact of
Inadequate Temperature Storage Conditions on Aggregate and Particle
Formation in Drugs Containing
Tumor Necrosis Factor-Alpha Inhibitors. Pharm. Res. 2018;35(42).
21. Kueltzo LA, Middaugh CR. Ultravioloet absorption spectroscopy. In:
Jiskoot W, Crommelin DJA, editors. Methods
for structural analysis of protein pharmaceuticals. Arlington: AAPS
Press; 2005.
22. R Core Team (2017). R: A language and environment for statistical
computing. R Foundation for
Statistical Computing, Vienna, Austria. URL: https://www.R-project.org/.
23. Berends SE, Strik AS, Van Selm JC, Löwenberg M, Ponsioen CY, D’Haens
GR, et al. Explaining Interpatient Variability in Adalimumab
Pharmacokinetics in Patients with Crohn’s Disease. Ther Drug Monit.
2018;40(2):202–11.
24. Lindbom L, Ribbing J, Jonsson EN. Perl-speaks-NONMEM (PsN) - A Perl
module for NONMEM related programming. Comput Methods Programs Biomed.
2004;75(2):85–94.
25. Kim YC, Park JH, Prausnitz MR. Microneedles for drug and vaccine
delivery. Adv Drug Deliv Rev. 2012;64(14):1547–68.
26. Gill HS, Denson DD, Burris BA, Prausnitz MR. Effect of microneedle
design on pain in human volunteers. Clin J Pain. 2008;24(7):585–94.
27. Kim YC, Park JH, Prausnitz MR. Microneedles for drug and vaccine
delivery. Adv. Drug Deliv. Rev.2012;64(14):1547–1568.
28. Gupta J, Park SS, Bondy B, Felner EI, Prausnitz MR. Infusion
pressure and pain during microneedle injection into skin of human
subjects. Biomaterials. 2011;32(28)6823-31.
29. Usach I, Martinez R, Festini T, Peris JE. Subcutaneous Injection of
Drugs: Literature Review of Factors Influencing Pain Sensation at the
Injection Site. Adv Ther. 2019;36(11):2986–96.
30. Mathaes R, Koulov A, Joerg S, Mahler HC. Subcutaneous Injection
Volume of Biopharmaceuticals—Pushing the Boundaries. J. Pharm.
Sci. 2016;105(8):2255–2259.
31. Heise T, Nosek L, Dellweg S, Zijlstra E, Praestmark KA, Kildegaard J
… Sparre T. Impact of injection speed
and volume on perceived pain during subcutaneous injections into the
abdomen and thigh: a single-
centre, randomized controlled trial. Diabetes, Obes. Metab.2014;16(10):971–976.
32. Jørgensen JT, Rømsing J, Rasmussen M, Møller-Sonnergaard J, Vang L,
Musæus L. Pain assessment of subcutaneous injections. Ann Pharmacother.
1996;30(7–8):729–32.
33. Richter WF, Bhansali SG, Morris ME. Mechanistic determinants of
biotherapeutics absorption following SC administration. AAPS J.
2012;14(3):559–70.
34. Supersaxo A, Hein WR, Steffen H. Effect of molecular weight on the
lymphatic absorption of water-soluble
compounds following subcutaneous administration. Pharm. Res.1990;7(2):167–9.
35. O’Morchoe CCC, Jones WR, Jarosz HM. Temperature dependence of
protein transport across lymphatic endothelium in vitro. J Cell Biol.
1984;98(2):629–40.
36. Astrup A, Bülow J, Madsen J. Skin temperature and subcutaneous
adipose blood flow in man. Scand J Clin Lab Invest. 1980;40(2):135–8.
37. Olszewski W, Engeset A, Icger PM, Sokolowski J, Theodorsen L. Flow
and Composition of Leg Lymph in Normal Men during Venous Stasis,
Muscular Activity and Local Hyperthermia. Acta Physiol Scand.
1977;99(2):149–55.
38. Ryan TJ, Mortimer PS, Jones RL. Lymphatics of the Skin: Neglected
but Important. Int J Dermatol. 1986;25(7):411–9.
39. Blatter C, Meijer EFJ, Nam AS, Jones D, Bouma BE, Padera TP, Vakoc
BJ. In vivo label-free measurement of lymph flow velocity and volumetric
flow rates using Doppler optical coherence tomography. Sci.
Rep.2016;6:29035.
40. Dul M, Stefanidou M, Porta P, Serve J, O’Mahony C, Malissen B, et
al. Hydrodynamic gene delivery in human skin using a hollow microneedle
device. J Control Release. 2017;265:120–31.
41. Rini CJ, McVey E, Sutter D, Keith S, Kurth HJ, Nosek L, et al.
Intradermal insulin infusion achieves faster insulin action than
subcutaneous infusion for 3-day wear. Drug Deliv Transl Res.
2015;5(4):332–45.
42. Kabashima K, Honda T, Ginhoux F, Egawa G. The immunological anatomy
of the skin. Nat. Rev. Immunol.2019;19(1):19–30.
43. Lambert PH, Laurent PE. Intradermal vaccine delivery: Will new
delivery systems transform vaccine administration? Vaccine.
2008;26(26):3197–208.
44. Prausnitz MR, Mikszta JA, Cormier M, Andrianov AK. Microneedle-Based
Vaccines. Curr Top Microbiol Immunol. 2009;333:369-93.
45. Büttel IC, Chamberlain P, Chowers Y, Ehmann F, Greinacher A,
Jefferis R … Schneider CK. Taking immunogenicity assessment of
therapeutic proteins to the next level. Biologicals2011;39(2):100–109.
46. Rittié L, Fisher GJ. Natural and sun-induced aging of human skin.Cold Spring Harb. Perspect. Med. 2015;5(1):1–14.